“This dual-pathway antiplatelet therapy was shown to be more … aspirin alone and more effective and safer than aspirin and vitamin K antagonists.4–6 In this context, the achievement of … and consistent inhibition of the target receptor through prasugrel7 or ticagrelor8 has resulted in … of the ischemic outcomes.”